Cost Effectiveness Analysis (CEA) of Antihypertensives Use in Inpatient Hemodialysis Patients at Abdoel Wahab Sjahranie Hospital Samarinda
DOI:
https://doi.org/10.12928/mf.v22i1.30730Abstract
Hypertension is the first comorbid disease that can occur in patients with damaged kidney function. Apart from that, hypertension is a complicating disease that often occurs during the hemodialysis process. The large variations in the use of antihypertensives in patients with chronic renal failure on hemodialysis therapy can affect the cost incurred by these patients. The purpose of this study was to optimize the use of the most cost-effective and pharmacological antihypertensive drugs in patients undergoing hemodialysis therapy. This research is a descriptive study with a pharmacoeconomic approach using the Cost Effectiveness Analysis (CEA) method. The measurement indices used to analyze the data are ACER and ICER. Data collection was conducted retrospectively, taken from the medical records of inpatient hemodialysis patients by reviewing the inclusion data of patients who were eligible to be research objects. Direct medical costs were taken from the average cost of hemodialysis, other procedures, room costs and drug costs. The effectiveness of drug therapy was determined based on the Mean Arterial Pressure (MAP) value that met the normal value. Research data is grouped based on therapy patterns and then analyzed to obtain cost – effective therapy. The results of the study showed that the percentage effectiveness of antihypertensive therapy with Furosemide was 46%, the combination of Amlodipine and Candesartan was 69% and the combination of Furosemide, Amlodipine, and Candesartan was 56%. Based on the ACER value of Rp. 1,726,133.4, the combination of antihypertensive Amlodipine and Candesartan is the most cost-effective therapy option and based on the ICER value of Rp. -6,697,330.3, the combination of antihypertensive Amlodipine and Candesartan is also the most cost-effective therapy option.
References
Ariyani, H., Hilmawan, R. G., S., B. L., Nurdianti, R., Hidayat, R., & Puspitasari, P. (2019). Gambaran Karakteristik Pasien Gagal Ginjal Kronis di Unit Hemodialisa Rumah Sakit Umum Dr. Soekardjo Kota Tasikmalaya. Keperawatan & Kebidanan, 3 No 2(November), 1–6.
Artiany, S., Gamayana Trimawang Aji, Y., & Yenny. (2021). Gambaran Komorbid pada Pasien Hemodialisis di Rumah Sakit Angkatan Udara (RSAU) drEsnawan Antariksa. Jurnal Keperawatan Cikini, 2(2), 1–6. https://doi.org/10.55644/jkc.v2i2.57
Auliafendri, N., & Khairiati, R. (2022). Evaluasi Penggunaan Obat Antihipertensi Pada Pasien Gagal Ginjal Kronik (GGK) Di Unit Hemodialisa RSU Imelda Pekerja Indonesia Medan. JIFI (Jurnal Ilmiah Farmasi Imelda), 6(1), 22–29. https://doi.org/10.52943/jifarmasi.v6i1.1116
Baroleh, J. M., Ratag, T. B., G, F. L. F., & Langi. (2019). Faktor-Faktor Yang Berhubungan Dengan Penyakit Ginjal Kronis Pada Pasien Di Instalasi Rawat Jalan RSU Pancaran Kasih Manado. Kesmas, 8(7), 8. https://ejournal.unsrat.ac.id/index.php/kesmas/article/view/27233
Bello, A. K., Okpechi, I. G., Osman, M. A., Cho, Y., Htay, H., Jha, V., Wainstein, M., & Johnson, D. W. (2022). Epidemiology Of Haemodialysis Outcomes. Nature Reviews Nephrology, 18(6), 378–395. https://doi.org/10.1038/s41581-022-00542-7
Erfika, L. L., Kaaffah, S., & Kurniasih, K. I. (2024). Cost Effectiveness Analysis Kombinasi Amlodipin-Kandesartan Dibandingkan Amlodipin-Irbesartan Pada Hipertensi Komorbid Diabetes Mellitus Tipe 2 Di RSUD Goeteng Taroenadibrata. Journal Syntax Idea, 6.
Ferdianto, A., & Rizaldy, I. (2023). Efisiensi Penggunaan Tempat Tidur Di Unit Rawat Inap Berdasarkan Grafik Barber Johnson Di RSU Anna Medika Madura. Jurnal Keperawatan Muhammadiyah, 93. https://doi.org/10.30651/jkm.v0i0.17881
Gusti, I., Puja, A., Dewi, A., Parut, A. A., Institut, D., Dan, T., Bali, K., Tukad Balian, J., & 180 Renon, N. (2019). Penyulit Dominan Yang Dialami Selama Intradialisis Pada Pasien Yang Menjalani Terapi Hemodialisis Di BRSU Tabanan-Bali Dominant Complications That Occur During Intradialisis on Patients Undergoing Hemodialysis Therapy in BRSU Tabanan-Bali. Jurnal Riset Kesehatan Nasional , Vol.3 No.2, 56–61.
Haase, S. B., Chang, S., Brigitte Schiller, M., Glenn M. Chertow, MD, M., & Tara I. Chang, MD, M. (2019). Antihypertensive Medication Withholding Practices in Hemodialysis: A Survey Study of Patients and Providers. Physiology & Behavior, 176(5), 139–148. https://doi.org/10.1111/hdi.12640.Antihypertensive
Haiya, N. N., Ardian, I., Azizah, I. R., & Marfu’ah, S. (2024). Investigasi Kualitas Hidup Pasien Hemodialisa Berdasarkan Aspek Dukungan Keluarga. Jurnal Gema Keperawatan, 17(1), 162–178. https://doi.org/10.33992/jgk.v17i1.3310
Husna, U. Y., Setyowati, E., Retnowati, E., Trinovitawati, Y., & Wahidah, N. (2024). Studi Evaluasi Efektivitas Penggunaan Antihipertensi Terhadap Tekanan Darah Pasien Hemodialisa Di RSI Sunan Kudus. 9, 2014.
Karwiti, W., & Umizah, L. P. (2023). Gambaran Kadar Ureum Pada Pasien Gagal Ginjal Kronik Yang Menjalani Hemodialisa Description of Ureum Levels in Chronic Renal Disease Patients With Hemodialysis. JMLS) Journal of Medical Laboratory and Science, 3(2), 2023. https://doi.org/10.36086/medlabscience.v3i2
Kovesdy, C. P. (2022). Epidemiology Of Chronic Kidney Disease: An Update 2022. Kidney International Supplements, 12(1), 7–11. https://doi.org/10.1016/j.kisu.2021.11.003
Lina, L. F., & Wahyu, H. (2019). Efektivitas Inovasi Intervensi Keperawatan Mengulum Es Batu Terhadap Penurunan Skala Haus Pasien Gagal Ginjal Kronik yang Menjalani Hemodialisis Di RSUD dr. M. Yunus Bengkulu. Jurnal Ilmiah, 10(2), 1–94.
Made Maharianingsih, N., Windidaca, D., Putri, B., Made, N., Jurusan, M., Klinis, F., Ilmu, F., & Kesehatan, I. (2024). Studi Penggunaan Obat Antihipertensi Pada Pasien Chronic Renal Failure. Indonesian Journal of Pharmaceutical Education (e-Journal), 4(1), 2775–3670. https://doi.org/10.37311/ijpe.v4i1.25489
Masruroh, N., & Santoso, A. P. R. (2020). Pemeriksaan Mean Arteri Pressure Dan Protein Urine Sebagai Prediksi Hipertensi Pada Ibu Hamil Trimester Iii Di RS Prima Husada Sidoarjo. Jurnal Midwifery, 2(2), 52–59. https://doi.org/10.24252/jm.v2i2a1
Murdeshwar, H. N., & Anjum, F. (2023). Hemodialysis. StatPearls Publishing.
Nusantara, D. T. H., Irawiraman, H., & Devianto, N. (2021). Perbandingan Kualitas Hidup Antara Pasien Penyakit Ginjal Kronik yang Menjalani Terapi CAPD dengan Hemodialisis di RSUD Abdul Wahab Sjahranie Samarinda. Jurnal Sains Dan Kesehatan, 3(3), 365–369. https://doi.org/10.25026/jsk.v3i3.299
Omega, K. D., Putri, K. P. A., Marcory, Y. S., Juhdeliena, & Wikliv, S. (2023). Perbedaan Tekanan Darah Intradialisis Pada Pasien Gagal Ginjal Kronik yang Menjalani Hemodialisis. Jurnal Keperawatan Cikini, 4(1), 87–93.
PENEFRI. (2008). Pedoman Pelayanan Hemodialisis di Sarana Pelayanan Kesehatan. DirDepkes RI. (2008). Pedoman Pelayanan Hemodialisis Di Sarana Pelayanan Kesehatan. Direktorat Bina Pelayanan Medik Spesialistik Direktorat Jenderal Bina Pelayanan Medik Departemen Kesehatan Republik Indonesia, 8–9. Https://Www.Pernefri.Org/Konsensus/PEDO, 8–9. https://www.pernefri.org/konsensus/PEDOMAN Pelayanan HD.pdf
PERNEFRI. (2020). 13th Annual Report of Indonesian Renal Registry 2020. Indonesian Renal Registry (IRR), 13, 11. https://www.indonesianrenalregistry.org/data/IRR 2018.pdf
Ray, N., & Reddy, P. H. (2023). Structural And Physiological Changes Of The Kidney With Age And Its Impact on Chronic Conditions and COVID-19. Ageing Research Reviews, 88(April), 101932. https://doi.org/10.1016/j.arr.2023.101932
Sarman Agustani, Suparman, R., Setianingsih, T., & Mamlukah. (2021). Analisis Faktor-Faktor Yang Berhubungan Dengan Kepatuhan Pasien Penderita Gagal Ginjal Kronik Dalam Menjalani Terapi. Jurnal Ilmiah, 2(02), 113–122. https://ejournal.stikku.ac.id/index.php/jphi/article/view/411%0Ahttp://ojs.poltekkes-medan.ac.id/pannmed/article/view/298
Tuladhar, L. R., Manandhar, D., Ansari, S., Khadka, N., Regmi, D., & Shrestha, B. L. (2023). Antihypertensive Medications Use among Chronic Hemodialysis Patients Visiting the Outpatient Department of Nephrology of a Tertiary Care Centre: A Descriptive Cross-sectional Study. Journal of the Nepal Medical Association, 61(259), 255–258. https://doi.org/10.31729/jnma.8095
Wulandari, C., Setiani, L. A., Zunnita, O., & Ikramin, M. (2023). Cost Effectiveness Analysis Kombinasi Obat Anhipertensi Pada Pasien Hipertensi Rawat Jalan Di RSUP Fatmawati Jakarta Periode 2020. Jurnal Farmamedika (Pharmamedica Journal), 8(2), 200–208. https://doi.org/10.47219/ath.v8i2.293
Wulandari, W., Suwantika, A. A., Zakiyah, N., Rahayu, C., & Ramadhani, S. F. (2023). Perbandingan Pemilihan Obat Antihipertensi pada Pasien Penyakit Ginjal Tahap Akhir yang Melakukan Hemodialisis dan Continuous Ambulatory Peritoneal Dialysis Comparison of Antihypertensive Drug Selection in End-Stage Renal Disease Patients Undergoing Hemod. 12(2). https://doi.org/10.15416/ijcp.2023.12.2.98
Yanti Rosalina Pasaribu, Sefti S.J. Rompas, & Rina Margaretha Kundre. (2021). Perbedaan Tekanan Darah Pada Pasien CKD Sebelum Dan Setelah Hemodialisis Di Ruang Hemodialisa RS swasta Di Sulawesi Utara. Jurnal Keperawatan, Volume 9,(1).
Yanti, W. V., Warnida, H., Sentat, T., & Janan, P. L. (2022). Analisis Efektivitas Biaya Metode Kb Dan Kualitas Hidup Akseptor Di Puskesmas Loa Janan. Jurnal Riset Kefarmasian Indonesia, 4(2), 230–246. http://jurnalfarmasi.or.id/index.php/jrki/article/view/237/150
Yaqoob, S., Yaseen, M., Abdullah, H., Jarullah, F. A., & Khawaja, U. A. (2020). Sexual Dysfunction and Associated Anxiety and Depression in Female Hemodialysis Patients: A Cross-Sectional Study at Karachi Institute of Kidney Diseases. Cureus, 12(8). https://doi.org/10.7759/cureus.10148
Zulfah, M. (2019). Analisis Efektivitas Biaya Kombinasi Obat Antihipertensi Pada Pasien Rawat Inap Di RSUD Dr. Soekardjo Tasikmalaya. Journal of Pharmacopolium, 2(1), 53–62. https://doi.org/10.36465/jop.v2i1.472
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Diah Sri Setianingsih, Deasy Nur Chairin Hanifa
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with Media Farmasi agree to the following terms:
- Authors retain copyright and grant the journal the right of first publication with the work simultaneously licensed under a Creative Commons Attribution License (CC BY-SA 4.0) that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
This work is licensed under a Creative Commons Attribution 4.0 International License
